Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen–Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies
Elad Jacoby(National Institutes of Health), Heather J. Symons(Johns Hopkins University), David M. Loeb(Albert Einstein College of Medicine), Jeffrey S. Huo, Christopher Gamper(Johns Hopkins University), Kenneth R. Cooke(Sidney Kimmel Comprehensive Cancer Center), Nicolás J. Llosa(Sidney Kimmel Comprehensive Cancer Center), Ephraim J. Fuchs(Johns Hopkins Hospital), Allen Chen(Johns Hopkins University), Elias T. Zambidis(University of Maryland, Baltimore), Rick Jones(Johns Hopkins University), Leo Luznik(Sidney Kimmel Comprehensive Cancer Center)
Cited by 46
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
|Cancer Discovery|2014|1.5k
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
|Biology of Blood and Marrow Transplantation|2009|595
B Cells Turn Off Virgin But Not Memory T Cells
|Science|1992|570